We are live on ! Find out more
YTEN

Yield10 Bioscience, Inc. Common Stock
YTEN

Delisted

YTEN was delisted on the 15th of May, 2024.

Back to rankings

15 hedge funds and large institutions have $10.3M invested in Yield10 Bioscience, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

12% more capital invested

Capital invested by funds: $9.2M → $10.3M (+$1.09M)

7% more funds holding

Funds holding: 14 → 15 (+1)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.4%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
2
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OIM
Oracle Investment Management
Connecticut
+$1.65M
2
FA
FCG Advisors
New Jersey
+$137K
3
CCB
Cutter & Co Brokerage
Missouri
+$34.3K

Top Sellers

Rank Fund Capital Flow
1
AG
Aperio Group
California
-$76K
2
BIT
BlackRock Institutional Trust
California
-$34.3K
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$34.3K
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$21K
5
GA
Geneva Advisors
Illinois
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Birchview Capital
Vermont
$5.07M +$7.58M +221 New
OIM
2
Oracle Investment Management
Connecticut
$3.28M +$1.65M +48 +53%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$792K -$34.3K -1 -3%
BIT
4
BlackRock Institutional Trust
California
$380K -$34.3K -1 -6%
FA
5
FCG Advisors
New Jersey
$305K +$137K +4 +44%
Vanguard Group
6
Vanguard Group
Pennsylvania
$215K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$52K – – –
MCM
8
McRae Capital Management
New Jersey
$32K – – –
Northern Trust
9
Northern Trust
Illinois
$23K – – –
Bank of New York Mellon
10
Bank of New York Mellon
New York
$20K – – –
Goldman Sachs
11
Goldman Sachs
New York
$19K – – –
Stifel Financial
12
Stifel Financial
Missouri
$17K – – –
William Blair & Company
13
William Blair & Company
Illinois
$17K – – –
CCB
14
Cutter & Co Brokerage
Missouri
$17K +$34.3K +1 New
Morgan Stanley
15
Morgan Stanley
New York
$13K – – –
HighTower Advisors
16
HighTower Advisors
Illinois
$10K – – –
Deutsche Bank
17
Deutsche Bank
Germany
$8K – – –
UBS Group
18
UBS Group
Switzerland
$7K – – –
State Street
19
State Street
Massachusetts
$6K – – –
TWA
20
TCI Wealth Advisors
Arizona
$3K – – –
BA
21
BlackRock Advisors
Delaware
$2K – – –
BPBT
22
Boston Private Bank & Trust
Massachusetts
$2K – – –
Creative Planning
23
Creative Planning
Kansas
$1K – – –
PSC
24
Prentiss Smith & Co
Vermont
$1K – – –
AIG
25
American International Group
New York
$412 – – –
1
2

YTEN Hedge Fund Activity: Q4 2014 in Review

15 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q4 2014, worth a combined $10.3M — up 12% from $9.2M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new YTEN positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Oracle Investment Management, adding an estimated $1.65M. The largest seller was Aperio Group, exiting entirely with an estimated $76K sold.

  • 15 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q4 2014, up from 14 in Q3 2014.
  • Funds reported $10.3M of Yield10 Bioscience, Inc. Common Stock stock for Q4 2014, up 12% quarter-over-quarter.
  • 2 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q4 2014 and 1 closed out, a net change of +1 holder.
  • The largest Yield10 Bioscience, Inc. Common Stock buyer in Q4 2014 was Oracle Investment Management, an estimated $1.65M added.
  • The largest Yield10 Bioscience, Inc. Common Stock seller in Q4 2014 was Aperio Group, an estimated $76K sold.

Based on aggregated 13F filings for Q4 2014.